BioSpace News Archive

By using mobile-first technology, one hospital connects resources and clinicians in real-time for consultation, collaboration, and human connection during the COVID-19 pandemic

Kidney patients are among the high-risk groups of people with chronic medical conditions who may experience more serious COVID-19 illness . While kidney patients are being encouraged to stay home and avoid crowds as much as possible during the outbreak, those treated with in-center hemodialysis must also continue their scheduled dialysi

GVOKE Pre-Filled Syringe (PFS) is available for home delivery through PillPack by Amazon Pharmacy

COVID-19 continues to spread across the world, especially in Europe. According to John Hopkins University’s latest real-time statistics, as of 10:00 a.m.

Agritek Holdings, Inc. (AGTK) www.AgritekHoldings.com, a fully integrated, active real estate investor and white label provide for popular hemp brands, today announced that the Company has completed the acquisition and definitive agreement to acquire all of the issued and outstanding shares of Full Spectrum Biosciences Inc.,

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company is pleased to announce that Novotech, a leading Asia-Pacific clinical research organization (CRO), has identified physicians in South Korea who have agreed to conduct an investigator initiated phase 2 clinical trial of Ifenprodil for coronavirus patients. The investigators

Surveillance program underway; Antech to report any suspected emergence of virus to veterinary health organizations

Zymergen Announces Acquisition of enEvolv, Accelerating Ability to Deliver High-Value Products to Market

Publicly available resource monitors development of therapies to treat and prevent disease

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE) has been issued Australian Patent AU2015204609B2